Dr+Vet attends Iberzoo+Propet2023

Iberzoo+Propet2023, the international trade fair for pet professionals, was held in Madrid from March 15 to 17

This year Iberzoo+Propet has been as interesting as expected, showing the great variety of products and services dedicated to the welfare of pets.

From Dr+Vet we have taken the opportunity to announce the official launch of our new products of the digestive and metabolic lines:

· Digestum for nutritional support and improvement of symptomatology in patients with chronic gastroenteritis.

· Colitum for nutritional support and improvement of symptomatology in patients with chronic large bowel diarrhea.

· Flavum for nutritional support and improvement of symptomatology in patients with liver damage.

· Glyco for nutritional support and aid in glucose regulation (diabetes mellitus).

The 4 new products, as well as Lacrimalis+, will be available to veterinary professionals next April.

In addition, we have also carried out a raffle of a lot of all Dr+Vet products, of which the winner will be announced in April, coinciding with the launch of the new products. The announcement will be made through our social media and email.

Thanks to all of you who came to our stand at IberzooPropet! To have been able to share these days with you and receive your good feelings reinforces our tireless commitment to the welfare of companion animals.

Dr+Vet, presents its products at Iberzoo + Propet’2020

Dr.Vet, presenta sus productos en Iberzoo+Propet’2020.

From March 5 to 7, 2020, the fourth edition of the Iberzoo + Propet'2020 International Fair for the Pet Animal Professional was held in Hall 10 of the Feria de Madrid-IFEMA fairgrounds, where Dr.Vet presented in his stand, its various ranges of nutraceutical products designed exclusively by Böthmen Pharma laboratories, based on a rigorous R&D process, aimed at alleviating and preventing pathologies linked to animal health, especially in dogs and cats.

The innovative ophthalmological line indicated for animals with pathologies linked to glaucoma, cataracts, retina and dry eye, aroused great interest among the more than 16,000 attendees at the event and was selected among more than 250 companies for the innovation gallery aimed at the most innovative and shown to the public during the 3 days of exhibition.